๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The impact of endpoint measures in rheumatoid arthritis clinical trials

โœ Scribed by Agnes van der Heide; Johannes W.G. Jacobs; Huibert J. Dinant; Johannes W.J. Bijlsma


Book ID
113214341
Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
767 KB
Volume
21
Category
Article
ISSN
0049-0172

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Clinical Trial of Penicillamine in Rheum
โœ Norman O. Rothermich; Marvin H. Thomas; Vol K. Phillips; Waldemar Bergen ๐Ÿ“‚ Article ๐Ÿ“… 1981 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 532 KB

## Abstract The medical records of our first 200 consecutive rheumatoid arthritis patients treated with penicillamine were analyzed retrospectively. All but 5 patients (97.5%) had undergone earlier chrysotherapy that resulted in either therapeutic failure or toxicity. Only 57 patients (28.5%) were